S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
Free Trial
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free CVSI Stock Alerts
$0.04
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.03
▼
$0.04
50-Day Range
$0.03
▼
$0.04
52-Week Range
$0.03
▼
$0.06
Volume
274,474 shs
Average Volume
302,337 shs
Market Capitalization
$6.01 million
P/E Ratio
1.84
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest
CVSI stock logo

About CV Sciences Stock (OTCMKTS:CVSI)

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

CVSI Stock Price History

CVSI Stock News Headlines

April 1, 2024 | finance.yahoo.com
CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript
March 28, 2024 | investorplace.com
CVSI Stock Earnings: CV Sciences Reported Results for Q4 2023
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 28, 2024 | prnewswire.com
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
March 27, 2024 | wsj.com
CV Sciences Inc.
March 26, 2024 | finance.yahoo.com
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
March 21, 2024 | prnewswire.com
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
February 22, 2024 | benzinga.com
CV Sciences Stock (OTC:CVSI), Short Interest Report
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
December 12, 2023 | finance.yahoo.com
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
November 15, 2023 | nz.finance.yahoo.com
The Best Shampoo for Thinning Hair We Tested Is 30% Off Right Now
November 15, 2023 | finance.yahoo.com
CV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call Transcript
November 14, 2023 | benzinga.com
Hemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%
November 14, 2023 | msn.com
CV Sciences GAAP EPS of $0.00, revenue of $4.09M
November 14, 2023 | finance.yahoo.com
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
November 12, 2023 | morningstar.com
CV Sciences Inc CVSI
November 9, 2023 | finance.yahoo.com
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
September 5, 2023 | finance.yahoo.com
CV Sciences, Inc. Launches Reserve Sleep Gummies
August 15, 2023 | finance.yahoo.com
CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript
August 14, 2023 | seekingalpha.com
CV Sciences GAAP EPS of -$0.01, revenue of $4M
August 14, 2023 | benzinga.com
Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know
August 14, 2023 | finance.yahoo.com
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
August 1, 2023 | finance.yahoo.com
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
July 8, 2023 | finance.yahoo.com
CVSI - CV Sciences, Inc.
June 1, 2023 | finance.yahoo.com
CV Sciences to Participate in LD Micro Invitational Conference
May 15, 2023 | msn.com
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
May 15, 2023 | finance.yahoo.com
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
See More Headlines
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
CUSIP
N/A
CIK
1510964
Web
www.cvsciences.com
Phone
(866) 290-2157
Fax
619-876-4321
Employees
42
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$0.02
Trailing P/E Ratio
2.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.10 million
Net Margins
19.38%
Pretax Margin
19.34%
Return on Equity
80.98%
Return on Assets
30.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.30
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$16 million
Price / Sales
0.41
Cash Flow
$0.02 per share
Price / Cash Flow
1.80
Book Value
$0.02 per share
Price / Book
2.00

Miscellaneous

Outstanding Shares
163,230,000
Free Float
163,032,000
Market Cap
$6.53 million
Optionable
Not Optionable
Beta
0.62
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Joseph D. Dowling (Age 67)
    CEO, Secretary & Director
    Comp: $298.98k
  • Mr. Joerg Grasser (Age 49)
    Chief Financial Officer
    Comp: $210.47k
  • Mr. Tim Hitchman
    Vice President of Operations
  • Mr. Jesse Karagianes
    Senior Vice President of Revenue Growth
  • Ms. Alyssa Dunn
    Operations Manager

Key Competitors

View All Competitors

CVSI Stock Analysis - Frequently Asked Questions

How have CVSI shares performed in 2024?

CV Sciences' stock was trading at $0.0354 at the start of the year. Since then, CVSI shares have increased by 13.0% and is now trading at $0.04.
View the best growth stocks for 2024 here.

Are investors shorting CV Sciences?

CV Sciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 27,600 shares, an increase of 305.9% from the March 15th total of 6,800 shares. Based on an average daily volume of 818,700 shares, the days-to-cover ratio is currently 0.0 days.
View CV Sciences' Short Interest.

How were CV Sciences' earnings last quarter?

CV Sciences, Inc. (OTCMKTS:CVSI) released its quarterly earnings results on Thursday, March, 28th. The company reported ($0.01) earnings per share for the quarter. The business earned $3.80 million during the quarter. CV Sciences had a net margin of 19.38% and a trailing twelve-month return on equity of 80.98%.

What other stocks do shareholders of CV Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), Organigram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA).

How do I buy shares of CV Sciences?

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CVSI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research